Skip to main content
. 2020 May 7;30(5):688–695. doi: 10.1089/thy.2019.0359

Table 2.

Characteristics of the Retropharyngeal Lymph Node Metastases

Characteristic No. of patients (%)
Whole cohort (n = 65) Observation (n = 25) Nonsurgical (n = 13) Surgery (n = 27)
Time of RPM diagnosis
 Initial presentation 12 (18.5) 3 (12.0) 1 (7.7) 8 (29.6)
 Recurrent disease 53 (81.5) 22 (88.0) 12 (92.3) 19 (70.4)
RPM location
 Ipsilateral 52 (80.0) 18 (72.0) 10 (76.9) 24 (88.9)
 Contralateral 7 (10.8) 4 (16.0) 2 (15.4) 1 (3.7)
 Bilateral 2 (3.1) 1 (4.0) 1 (7.7) 0
 Unknown 4 (6.2) 2 (8.0) 0 2 (7.4)
Median maximum RPM diameter 1.3 (0.4–4.2) cm 1.1 (0.4–4.1) cm 1.2 (0.7–2.4) cm 2.0 (0.8–4.2) cm
Concurrent disease at RPM diagnosisa
 None 20 (30.8) 8 (32.0) 2 (15.4) 10 (37.0)
 Locoregional 40 (61.5) 15 (60.0) 10 (76.9) 15 (55.6)
 Distant 15 (23.1) 4 (16.0) 6 (46.2) 5 (18.5)
Previous or concomitant MRND
 Yes 60 (92.3) 21 (84.0) 12 (92.3) 27 (100)
 No 5 (7.7) 4 (16.0) 1 (7.7) 0
Imaging for RPM detection
 CT 44 (67.7) 19 (76.0) 9 (69.2) 16 (59.3)
 MRI 15 (23.1) 4 (16.0) 1 (7.7) 10 (37.0)
 PET 3 (4.6) 2 (8.0) 0 1 (3.7)
131I RAI 3 (4.6) 0 3 (23.1) 0
Median follow-up from RPM diagnosis 35 (2–228) months 28 (2–182) months 32 (4–102) months 56 (5–228) months
a

Some patients had both locoregional and distant concurrent disease.

CT, computed tomography; MRI, magnetic resonance imaging; MRND, modified radical neck dissection; PET, positron emission tomography; RAI, radioactive iodine; RPM, retropharyngeal lymph node metastasis.